Mitsukazu Kitada

2.2k total citations
80 papers, 1.9k citations indexed

About

Mitsukazu Kitada is a scholar working on Pharmacology, Molecular Biology and Oncology. According to data from OpenAlex, Mitsukazu Kitada has authored 80 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 61 papers in Pharmacology, 27 papers in Molecular Biology and 26 papers in Oncology. Recurrent topics in Mitsukazu Kitada's work include Pharmacogenetics and Drug Metabolism (59 papers), Drug Transport and Resistance Mechanisms (26 papers) and Metabolism and Genetic Disorders (16 papers). Mitsukazu Kitada is often cited by papers focused on Pharmacogenetics and Drug Metabolism (59 papers), Drug Transport and Resistance Mechanisms (26 papers) and Metabolism and Genetic Disorders (16 papers). Mitsukazu Kitada collaborates with scholars based in Japan. Mitsukazu Kitada's co-authors include Tetsuya Kamataki, Masayuki Komori, K. Itahashi, Haruo Kitagawa, Shigeru Ohmori, Yoshio Kanakubo, Tadaaki Rikihisa, Itsuko Ishii, Kazuei Igarashi and Seiyu Hirose and has published in prestigious journals such as Biochemistry, Biochemical and Biophysical Research Communications and FEBS Letters.

In The Last Decade

Mitsukazu Kitada

79 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mitsukazu Kitada Japan	23	1.3k	588	555	212	197	80	1.9k
T. Kamataki Japan	9	989 0.8×	675 1.1×	424 0.8×	161 0.8×	159 0.8×	13	1.7k
George B. Corcoran United States	27	1.4k 1.1×	843 1.4×	596 1.1×	203 1.0×	99 0.5×	63	3.2k
F. Peter Guengerich United States	18	1.7k 1.3×	624 1.1×	705 1.3×	320 1.5×	126 0.6×	28	2.2k
Masayuki Komori Japan	24	952 0.8×	732 1.2×	424 0.8×	204 1.0×	115 0.6×	70	1.7k
M V Martin United States	13	1.5k 1.2×	512 0.9×	701 1.3×	169 0.8×	189 1.0×	16	1.8k
P. Kremers Belgium	29	1.7k 1.4×	906 1.5×	916 1.7×	349 1.6×	346 1.8×	77	3.0k
A. H. Conney United States	31	940 0.8×	605 1.0×	277 0.5×	297 1.4×	248 1.3×	56	2.1k
S.B. West United States	15	1.4k 1.1×	720 1.2×	559 1.0×	261 1.2×	198 1.0×	20	1.9k
Dawn C. Davis United States	10	2.5k 2.0×	578 1.0×	935 1.7×	156 0.7×	92 0.5×	15	3.3k
Yoshiyasu Yabusaki Japan	28	1.4k 1.1×	1.1k 1.9×	445 0.8×	141 0.7×	352 1.8×	60	2.3k

Countries citing papers authored by Mitsukazu Kitada

Since Specialization

Citations

This map shows the geographic impact of Mitsukazu Kitada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mitsukazu Kitada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mitsukazu Kitada more than expected).

Fields of papers citing papers by Mitsukazu Kitada

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mitsukazu Kitada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mitsukazu Kitada. The network helps show where Mitsukazu Kitada may publish in the future.

Co-authorship network of co-authors of Mitsukazu Kitada

This figure shows the co-authorship network connecting the top 25 collaborators of Mitsukazu Kitada. A scholar is included among the top collaborators of Mitsukazu Kitada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mitsukazu Kitada. Mitsukazu Kitada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ariyoshi, Noritaka, Yoko Shimizu, Yukari Kobayashi, et al.. (2007). Identification and Partial Characterization of a Novel CYP2C9 Splicing Variant Encoding a Protein Lacking Eight Amino Acid Residues. Drug Metabolism and Pharmacokinetics. 22(3). 187–194. 6 indexed citations

Ishii, Itsuko, Masayuki Hata, Hiroyoshi Nakamura, et al.. (2006). Helices F–G Are Important for the Substrate Specificities of CYP3A7. Drug Metabolism and Disposition. 35(3). 484–492. 20 indexed citations

Ishii, Itsuko, Masayuki Hata, Yukari Kobayashi, et al.. (2006). Theoretical calculation of triazolam hydroxylation and endogenous steroid inhibition in the active site of CYP3A4. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics. 1774(2). 223–232. 3 indexed citations

Matsunaga, Tamihide, et al.. (2002). Molecular Cloning of Monkey CYP2C43 cDNA and Expression in Yeast. Drug Metabolism and Pharmacokinetics. 17(2). 117–124. 14 indexed citations

Hasegawa, Atsushi, Hiroyoshi Nakamura, Itsuko Ishii, et al.. (2002). Identification of Inhibitory Component in Cinnamon —O-Methoxycinnamaldehyde Inhibits CYP1A2 and CYP2E1—. Drug Metabolism and Pharmacokinetics. 17(3). 229–236. 18 indexed citations

Ishihara, Kazuhisa, Takayuki Asano, Yasuharu Mizuhara, et al.. (2001). Simultaneous determination of byak-angelicin and oxypeucedanin hydrate in rat plasma by column-switching high-performance liquid chromatography with ultraviolet detection. Journal of Chromatography B Biomedical Sciences and Applications. 753(2). 309–314. 19 indexed citations

Ohmori, Shigeru, et al.. (1998). Differential catalytic properties in metabolism of endogenous and exogenous substrates among CYP3A enzymes expressed in COS-7 cells. Biochimica et Biophysica Acta (BBA) - General Subjects. 1380(3). 297–304. 61 indexed citations

Tanaka, Einosuke, et al.. (1998). Trimethadione metabolism and microsomal monooxygenases in untreated and phenobarbital-treated rhesus monkeys. Comparative Biochemistry and Physiology Part C Pharmacology Toxicology and Endocrinology. 120(2). 317–320. 3 indexed citations

Ohmori, Shigeru, et al.. (1998). Metabolism of dacarbazine by rat liver microsomes contribution of CYP1A enzymes to dacarbazine N-demethylation.. PubMed. 26(4). 379–82. 13 indexed citations

10.

Ohmori, Shigeru, et al.. (1993). Studies on Cytochrome P450 Responsible for Oxidative Metabolism of Imipramine in Human Liver Microsomes.. Biological and Pharmaceutical Bulletin. 16(6). 571–575. 20 indexed citations

11.

Inaba, Noriyuki, Yoriko Ota, Yasuo Hirai, et al.. (1993). Immunohistochemical and Immunoelectron Microscopic Study of Cytochrome P‐450 of Human Fetal Livers (P‐450HFL_a): Implications for an Onco‐Feto‐Placental Enzyme. Asia-Oceania Journal of Obstetrics and Gynaecology. 19(3). 329–341. 5 indexed citations

12.

Ohi, Hiroaki, et al.. (1992). Toxicological sifnificance of dog liver cytochrome P-450: examination with the enzyme expressed in Saccharomycees cerevisiae using recombinant expression plasmid. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 269(1). 97–105. 9 indexed citations

13.

Nakura, Hironori, Hiroaki Ohi, Toshiaki Miura, et al.. (1991). Formation of an Antibacterial Metabolite from a New Macrolide Compound 23-O-Benzyl-5-mycaminosyl-tylonolide (TMC-101), by a Hepatic Microsomal Drug-Metabolizing Enzyme System.. Journal of Pharmacobio-Dynamics. 14(7). 377–383. 1 indexed citations

14.

Kitada, Mitsukazu, et al.. (1991). Four Forms of Cytochrome P‐450 in Human Fetal Liver: Purification and Their Capacity to Activate Promutagens. Japanese Journal of Cancer Research. 82(4). 426–432. 46 indexed citations

15.

Komori, Masayuki, et al.. (1990). Fetus-specific expression of a form of cytochrome P-450 in human livers. Biochemistry. 29(18). 4430–4433. 173 indexed citations

16.

Kitada, Mitsukazu, Hiroaki Ohi, Masayuki Komori, et al.. (1989). Interspecies homology of cytochrome P-450: toxicological significance of cytochrome P-450 cross-reactive with anti-rat P-448-H antibodies in liver microsomes from dogs, monkeys and humans. Mutation Research Letters. 226(3). 163–167. 12 indexed citations

17.

Kitada, Mitsukazu, Hiroaki Ohi, Masayuki Komori, et al.. (1989). Mutagenic activation of aflatoxin B1 by P-450 HFLa in human fetal livers. Mutation Research Letters. 227(1). 53–58. 27 indexed citations

18.

Miura, Toshiaki, et al.. (1988). Sex‐related difference in oxidative metabolism of testosterone and erythromycin by hamster liver microsomes. FEBS Letters. 231(1). 183–186. 11 indexed citations

19.

Kitada, Mitsukazu, Tetsuya Kamataki, K. Itahashi, et al.. (1988). Immunochemical similarity of P-450 HFLa, a form of cytochrome P-450 in human fetal livers, to a form of rat liver cytochrome P-450 inducible by macrolide antibiotics. Archives of Biochemistry and Biophysics. 264(1). 61–66. 22 indexed citations

20.

Kitada, Mitsukazu, Tetsuya Kamataki, & Haruo Kitagawa. (1974). Effects of Lipid Peroxidation on the Microsomal Electron Transport System and the Rate of Drug Metabolism in Rat Liver. Chemical and Pharmaceutical Bulletin. 22(4). 752–756. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact